Mojo is a sports stock market that allows you to bet on the career stats of athletes. Health and durability are a major consideration for you when deciding to Go Long or Go Short on a stock, (which is like taking the over or under on a traditional futures bet). Multipliers allow you to customize your risk and reward if you want to try and make more (and risk more) in a short period of time. The cool thing about multipliers is that your downside is capped at the value of your initial bet and you have unlimited upside on Long Multipliers.
After suffering a grade II MCL sprain of his right knee earlier this season that caused him to miss seven games, Mitchell (-8.7% since last week) has now been diagnosed with a MCL sprain of his left knee. It’s been reported that he will miss approximately 6-8 weeks, which indicates another grade II sprain.
Over the last calendar year this is Mitchell’s fourth knee “issue” (three separate injuries that have forced him to miss time, plus off-season knee surgery which was dubbed as a “clean up”). His share price of $5.39 currently sits at 54th among all RBs, between Rachaad White and Isiah Pacheco.
While the injuries have been mounting, his role in the vaunted ground attack of Kyle Shanahan’s offense cannot be understated. Be careful with future expectations of him, he appears to be someone who struggles to stay healthy.
Another injury to the San Fran backfield, although this one is far less severe. It was reported that CMC was battling through knee irritation in their win over the Saints. He was also seen wearing a brace that many athletes with patellar tendinitis wear. It’s unlikely that CMC (-1.76% over last week) will miss any time, and his share price of $19.46, 3rd highest among RBs, reflects this.
While CMC’s injury history has been undoubtedly worrisome, he has managed to avoid missing any game action this year thus far. He’s in line to see some increased usage over the next few weeks due to Elijah Mitchell’s MCL sprain. I like to view CMC as a Lamborghini that is only two years old… but already has 200,000 miles on it. He’s still technically young & in his prime, but I (Dr. Morse) believe that he has peaked and his decline has begun, which makes him a Short candidate.
Before you panic, no, Stevenson did not suffer an injury. However, his backfield mate, Damien Harris did. Harris was reportedly on crutches after the Pats Thanksgiving day loss against the Vikings, and is expected to miss a few weeks with a quad strain. What does this mean? Well, it’s Stevenson SZN, and it frankly has been all year long.
Stevenson has seen his share price increase 2.4% over the last week, and +40.9%(!!) over the last year. His share price currently sits at 34th highest among RBs, between Dameon Pierce and J.K. Dobbins. Stevenson has the rare traits to be one of the few bellcow backs in the NFL and has been able to stay very healthy despite sustaining large volumes. Add in the impending free agency of Harris, and we’re quite bullish on Stevenson now, and in the future. Go Long!
A rookie QB who’s elevated his play over the last few weeks, Pickett has seen his share price increase +37% over the last year. While his share price has decreased -1% over the last week, this could be due to the unknown severity of Najee Harris’ abdominal injury, which he suffered in their win against the Colts on Monday night, or his low passing volume in the MNF win (you need to put up stats to Bank Mojo Value). Pickett’s share price is currently 42nd highest among QBs, between Tyrod Taylor and Sam Darnold. Pickett has suffered a couple injuries throughout his career but none that are particularly concerning.
The market expects $17.34 in future value from Pickett, and as long as Pittsburgh continues to build its offensive line and skill players around him, it’s possible he could exceed this and be the starting QB in Pittsburgh for the next several years. Go Long!
After some uncertainty entering this game if Jacobs was going to play due to him suffering a calf strain in last Friday’s practice, he absolutely went OFF! Over 300 yards of total offense and 2 scores, Jacobs was the focal point of the Raiders offense in their thrilling OT win over Seattle. Jacobs did, however, aggravate the calf strain, causing him to miss some time in the 4th quarter before returning for OT and breaking out the game winning 86 yard TD run.
He most likely won’t practice for a few days, if at all, this week. It would be surprising if Jacobs were to miss any time, as he has only missed three games so far in his four year career. Jacobs’ monster performance saw his share price increase +6.12% over last week, and it has now increased +10.85% over the last month as Jacobs continues his stellar 2022 campaign. His share price of $15.91 is now 10th highest among RBs, between Aaron Jones and Dalvin Cook.
Injury-wise, Jacobs is one of those rare backs that tries to play through anything, as witnessed by last week’s impressive performance. Currently the RB2 in PPR, Jacobs has the potential and strong history of staying healthy to continue to be an underrated option and deliver you value. The market expects $7.07 in future value, and I think Jacobs, who is a pending free agent, should exceed this, depending on where he’s playing next year.
Written by: Dave Lorenz, DPT (@DLorenzDPT), Edited by: Jesse Morse, MD, CAQSM (@drjessemorse)